Answer in brief
CVE-2025-0416 records a Unknown severity vulnerability in Valmet DNA Local privilege escalation through insecure DCOM configuration. The current sources do not mark it as known exploited. The current feed maps Valmet/Valmet DNA (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
A CVSS score is not reported in the current record. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps Valmet/Valmet DNA (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| Valmet/Valmet DNAgeneric | C2007 | Not reported |
Published upstream
Apr 1, 2025
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Aug 26, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Aug 26, 2026
Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.
Quoted source text, attributed separately from HOL analysis.